Want to see HK:1833 full AI Analyst Report?
Ping An Healthcare and Technology Company (1833) Ratios
Ping An Healthcare and Technology Company Ratios
HK:1833's free cash flow for Q2 2026 was $57.71M. For the 2026 fiscal year, HK:1833's free cash flow was decreased by $-6.90M and operating cash flow was $64.61M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.70 | 1.02 | 4.30 | 3.61 | 3.47 |
| Quick Ratio | 2.68 | 1.02 | 4.24 | 3.54 | 3.36 |
| Cash Ratio | 0.75 | 0.16 | 0.60 | 1.07 | 0.83 |
| Solvency Ratio | 0.14 | 0.01 | -0.05 | -0.15 | -0.39 |
| Operating Cash Flow Ratio | 0.13 | 0.01 | -0.09 | -0.23 | -0.38 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 5.36B | $ 202.34M | $ 10.07B | $ 8.78B | $ 8.96B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.33 | 4.67 | 1.24 | 1.27 | 1.27 |
| Debt Service Coverage Ratio | 105.65 | 55.30 | -24.28 | -94.67 | -164.21 |
| Interest Coverage Ratio | 36.45 | -26.20 | -83.54 | -65.36 | -151.75 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.02 | 0.04 | 0.09 | 0.17 | 0.19 |
| Net Debt to EBITDA | -8.25 | -10.34 | 10.80 | 3.36 | 1.62 |
| Profitability Margins | |||||
| Gross Profit Margin | 32.41% | 31.68% | 32.28% | 26.93% | 23.27% |
| EBIT Margin | 3.86% | 2.02% | -6.95% | -18.09% | -25.07% |
| EBITDA Margin | 5.23% | 4.02% | -3.51% | -16.90% | -24.03% |
| Operating Profit Margin | 1.78% | -1.85% | -12.31% | -11.71% | -22.41% |
| Pretax Profit Margin | 6.96% | 1.95% | -7.10% | -10.25% | -20.77% |
| Net Profit Margin | 6.94% | 1.69% | -6.90% | -10.25% | -20.97% |
| Continuous Operations Profit Margin | 6.91% | 1.84% | -7.16% | -10.31% | -20.99% |
| Net Income Per EBT | 99.67% | 86.84% | 97.20% | 99.98% | 100.96% |
| EBT Per EBIT | 390.12% | -105.29% | 57.69% | 87.59% | 92.71% |
| Return on Assets (ROA) | 2.87% | 0.49% | -1.95% | -3.71% | -8.60% |
| Return on Equity (ROE) | 3.83% | 2.27% | -2.43% | -4.73% | -10.92% |
| Return on Capital Employed (ROCE) | 0.97% | -2.41% | -4.29% | -5.31% | -11.57% |
| Return on Invested Capital (ROIC) | 0.96% | -2.25% | -4.27% | -5.28% | -11.50% |
| Return on Tangible Assets | 3.29% | 0.54% | -2.18% | -4.13% | -9.15% |
| Earnings Yield | 1.45% | 1.22% | -1.86% | -3.13% | -6.04% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.62 | 3.39 | 3.46 | 3.64 | 4.48 |
| Payables Turnover | 5.25 | 3.85 | 3.56 | 5.55 | 4.95 |
| Inventory Turnover | 58.34 | 35.15 | 15.94 | 18.19 | 14.14 |
| Fixed Asset Turnover | 43.90 | 40.19 | 28.05 | 22.85 | 21.77 |
| Asset Turnover | 0.41 | 0.29 | 0.28 | 0.36 | 0.41 |
| Working Capital Turnover Ratio | 1.89 | 0.91 | 0.49 | 0.69 | 0.68 |
| Cash Conversion Cycle | 37.64 | 23.15 | 25.80 | 54.50 | 33.55 |
| Days of Sales Outstanding | 100.97 | 107.53 | 105.40 | 100.21 | 81.41 |
| Days of Inventory Outstanding | 6.26 | 10.38 | 22.90 | 20.07 | 25.82 |
| Days of Payables Outstanding | 69.58 | 94.76 | 102.50 | 65.78 | 73.67 |
| Operating Cycle | 107.22 | 117.91 | 128.30 | 120.28 | 107.23 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.21 | 0.09 | -0.26 | -0.75 | -1.27 |
| Free Cash Flow Per Share | 0.19 | 0.06 | -0.30 | -0.78 | -1.35 |
| Dividend Paid and CapEx Coverage Ratio | 0.11 | 0.01 | -6.58 | -23.54 | -15.74 |
| Capital Expenditure Coverage Ratio | 11.08 | 2.90 | -6.58 | -23.54 | -15.74 |
| Operating Cash Flow Coverage Ratio | 10.82 | 2.21 | -3.02 | -4.59 | -6.97 |
| Operating Cash Flow to Sales Ratio | 0.08 | 0.02 | -0.06 | -0.13 | -0.19 |
| Free Cash Flow Yield | 1.50% | 0.98% | -1.87% | -4.16% | -5.86% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 70.26 | 81.80 | -53.88 | -31.96 | -16.55 |
| Price-to-Sales (P/S) Ratio | 4.77 | 1.39 | 3.72 | 3.28 | 3.47 |
| Price-to-Book (P/B) Ratio | 2.63 | 1.86 | 1.31 | 1.51 | 1.81 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 66.59 | 102.34 | -53.34 | -24.06 | -17.06 |
| Price-to-Operating Cash Flow Ratio | 60.58 | 67.06 | -61.44 | -25.08 | -18.15 |
| Price-to-Earnings Growth (PEG) Ratio | 0.50 | -0.66 | 1.10 | 0.56 | -0.32 |
| Enterprise Value Multiple | 83.05 | 24.10 | -95.03 | -16.02 | -12.82 |
| Enterprise Value | 23.73B | 4.66B | 15.61B | 16.80B | 22.60B |
| EV to EBITDA | 83.05 | 24.10 | -95.03 | -16.02 | -12.82 |
| EV to Sales | 4.34 | 0.97 | 3.34 | 2.71 | 3.08 |
| EV to Free Cash Flow | 60.57 | 71.62 | -47.90 | -19.89 | -15.14 |
| EV to Operating Cash Flow | 55.10 | 46.93 | -55.18 | -20.73 | -16.11 |
| Tangible Book Value Per Share | 3.99 | 1.66 | 10.69 | 10.83 | 11.80 |
| Shareholders’ Equity Per Share | 4.81 | 3.17 | 12.30 | 12.45 | 12.77 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | 0.06 | -0.01 | -0.01 | -0.01 |
| Revenue Per Share | 2.65 | 4.24 | 4.33 | 5.74 | 6.65 |
| Net Income Per Share | 0.18 | 0.07 | -0.30 | -0.59 | -1.39 |
| Tax Burden | 1.00 | 0.87 | 0.97 | 1.00 | 1.01 |
| Interest Burden | 1.80 | 0.97 | 1.02 | 0.57 | 0.83 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.31 | 0.35 | 0.32 | 0.28 | 0.25 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Income Quality | 1.17 | 1.06 | 0.85 | 1.33 | 0.91 |
Currency in CNY
